Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals.
about
P1343
Transgenic rodent Plasmodium berghei parasites as tools for assessment of functional immunogenicity and optimization of human malaria vaccinesAlgae-produced Pfs25 elicits antibodies that inhibit malaria transmissionThe Use of Synthetic Carriers in Malaria Vaccine DesignVaccines for malaria: how close are we?Identification of three ookinete-specific genes and evaluation of their transmission-blocking potentials in Plasmodium bergheiParasites resistant to the antimalarial atovaquone fail to transmit by mosquitoesAnopheles stephensi salivary glands bear receptors for region I of the circumsporozoite protein of Plasmodium falciparumA region of Plasmodium falciparum antigen Pfs25 that is the target of highly potent transmission-blocking antibodiesProtective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: adjuvant effects on induction of protective immunity.Hundreds of dual-stage antimalarial molecules discovered by a functional gametocyte screenSaccharomyces cerevisiae-secreted fusion proteins Pfs25 and Pfs28 elicit potent Plasmodium falciparum transmission-blocking antibodies in mice.Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines.Structural and antigenic properties of merozoite surface protein 4 of Plasmodium falciparum.Engineered resistance to Plasmodium falciparum development in transgenic Anopheles stephensi.The IC(50) of anti-Pfs25 antibody in membrane-feeding assay varies among species.Current status of malaria and potential for control.Immunization of mice with DNA-based Pfs25 elicits potent malaria transmission-blocking antibodiesAntibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes.Blocking effect of a monoclonal antibody against recombinant Pvs25 on sporozoite development in Anopheles sinensis.Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparumEpidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and eliminationProgress toward a malaria vaccine: efficient induction of protective anti-malaria immunity.In vitro generation of Plasmodium falciparum ookinetes.Current developments in malaria transmission-blocking vaccines.Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization.Bacterial superglue enables easy development of efficient virus-like particle based vaccines.Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum.Qualification of standard membrane-feeding assay with Plasmodium falciparum malaria and potential improvements for future assaysMethodology and application of flow cytometry for investigation of human malaria parasites.Engineering the control of mosquito-borne infectious diseases.Antigenic repertoire of Plasmodium vivax transmission-blocking vaccine candidates from the Indian subcontinent.A plant-produced Pfs25 VLP malaria vaccine candidate induces persistent transmission blocking antibodies against Plasmodium falciparum in immunized mice.Antimalarial iron chelator FBS0701 blocks transmission by Plasmodium falciparum gametocyte activation inhibition.Recombinant Pvs48/45 antigen expressed in E. coli generates antibodies that block malaria transmission in Anopheles albimanus mosquitoesAlga-produced malaria transmission-blocking vaccine candidate Pfs25 formulated with a human use-compatible potent adjuvant induces high-affinity antibodies that block Plasmodium falciparum infection of mosquitoes.Genome-level determination of Plasmodium falciparum blood-stage targets of malarial clinical immunity in the Peruvian AmazonNYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines.Long-lasting and transmission-blocking activity of antibodies to Plasmodium falciparum elicited in mice by protein conjugates of Pfs25.Imaging-based high-throughput screening assay to identify new molecules with transmission-blocking potential against Plasmodium falciparum female gamete formation.
P2860
Q21032495-8C4BAF75-2E7C-4A82-BF39-B19EC2C11D10Q21134576-8072D1C6-034C-44B3-B627-C9675CDE458AQ26777053-34CBCA81-2424-4A28-9DC1-3004F247CF29Q27024344-2FEA9B38-A368-4A16-BD16-1EECD5F99F4BQ30043378-55C10111-72ED-45B9-B352-30D5D941808FQ30380109-5139A003-9862-46F6-A9AB-87727CA71552Q33570584-6E71A301-C6CD-4AB7-8DBC-5E99674DB3EAQ33591209-19BB29AC-A282-4CB6-AC43-4DC04FC7D0DBQ33596771-3C9A0875-69EF-4C01-8BDB-AF36FCD5270BQ33720859-5A6EC223-A869-4419-9337-70E1A28C12DEQ33747301-5B74F39D-E826-4060-8862-710570D158EEQ33812439-264786BC-B9EF-4412-9271-742856FBFC62Q33866986-AAC667F1-CC3F-4D3B-8DB4-4DD1284AA0AFQ33886121-811C5F0D-40F2-4772-A806-35CCFF8945EBQ33892507-A0739352-DEE4-4AA8-90DA-4BAFC22FF6E4Q33975652-ED816039-C2F1-4C69-AF74-8F0113137398Q34000822-58CF2B9E-BF78-4AC2-AF44-47E450A9233FQ34005142-B035A2FB-D494-4072-9289-6E298AF76D9EQ34045009-D6F1E3CA-4D34-4693-873A-E9AB4B0B1FDEQ34111897-0668EB4A-B894-4015-B773-4FC5BCC92D17Q34177472-4F584C59-8E49-4D58-BAD1-2094B68D471AQ34280935-3C92B6CC-F461-43C1-BF9F-CF2F2CEF6508Q34341749-00100CA1-A586-4E2A-A303-30063D8EFAE1Q34451883-3FDEC9AC-E402-432A-ACB5-8CD1973FD4C8Q34509612-396F00F4-74BC-4C2C-86B8-130DF2C8F081Q34523734-75714C4B-C917-4F8E-AEB8-F78401954C5FQ34548828-4EB7B87F-6329-48A7-9088-860AAF6A12CDQ34618434-8E5ED4FE-88D0-44B4-95C3-AA923A668367Q34765400-93D790E9-2289-4489-83DF-593C8E0A3711Q34803745-801128DE-6CE1-4006-BFE7-543DA71A83A6Q35014586-1F77051D-869F-49C7-9195-721B8E16D7E3Q35048518-84F9C1E2-0894-446B-89A9-8503EF2548D8Q35076873-114DB22F-25B4-4A1E-84FC-824B9C933A5DQ35182086-A056890D-F56C-4572-8706-24455868BB0FQ35439931-39189922-A293-44F9-96C2-4207B8010AF8Q35473530-064D6750-AF65-4836-A040-79B856252912Q35519418-E05233E4-97E3-4305-B4D5-F83B98821E99Q35544571-F41FC4C9-E73B-43BC-B4AB-2CEE81262CCAQ35575993-8720D27C-55E8-44F8-B96E-9497A0D0567FQ35584827-F2CF0760-5C87-4EFB-9BF0-8E092355DA78
P2860
Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Recombinant Pfs25 protein of P ...... unity in experimental animals.
@en
Recombinant Pfs25 protein of P ...... unity in experimental animals.
@nl
type
label
Recombinant Pfs25 protein of P ...... unity in experimental animals.
@en
Recombinant Pfs25 protein of P ...... unity in experimental animals.
@nl
prefLabel
Recombinant Pfs25 protein of P ...... unity in experimental animals.
@en
Recombinant Pfs25 protein of P ...... unity in experimental animals.
@nl
P2093
P2860
P921
P356
P1476
Recombinant Pfs25 protein of P ...... unity in experimental animals.
@en
P2093
P2860
P304
P356
10.1084/JEM.174.5.1203
P407
P4510
P577
1991-11-01T00:00:00Z